Page last updated: 2024-09-04

rhodioloside and Granulocytic Leukemia, Chronic

rhodioloside has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chai, Y; Chen, F; Li, Z; Liu, W; Xi, Y; Yang, P; Zhou, Q	1

Other Studies

1 other study(ies) available for rhodioloside and Granulocytic Leukemia, Chronic

Article	Year
Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023, Volume: 25, Issue:2 Topics: Drugs, Chinese Herbal; Glucosides; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Network Pharmacology	2023

Article

Year

Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023, Volume: 25, Issue:2

Topics: Drugs, Chinese Herbal; Glucosides; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Docking Simulation; Network Pharmacology

2023